http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104337817-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89d4789216ca49ed9ecf7b59f79cf11f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 |
| filingDate | 2013-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07a4891c6b8c906dbb6933de0e4940c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4a8b295e0560c068cba0263cdb3d622 |
| publicationDate | 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104337817-A |
| titleOfInvention | Suspending agent containing zolazepam hydrochloride and tiletamine hydrochloride salt and preparation method of suspending agent |
| abstract | The invention belongs to the technical field of veterinary analgesic suspending agent solutions and preparation methods, and particularly relates to a suspending agent containing zolazepam hydrochloride and tiletamine hydrochloride salt and a preparation method of the suspending agent. The suspending agent comprises (a) a zolazepam hydrochloride and tiletamine hydrochloride salt raw medicine, (b) a suspending aid, (c) a wetting agent, (d) a preservative and (e) a preservative. The suspending agent is prepared by adopting a dispersion method, and is a water mixed suspension which is off-white and slightly viscous. The suspending agent is high in stability, high in palatability, long in elimination half life, and high in bioavailability, and can be used as a veterinary oral preparation. |
| priorityDate | 2013-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.